Kennedy Promised Medical Freedom. New COVID-19 Vaccine Restrictions Present the Reverse
On Monday, I noticed an outlandish story revealed in The Every day Beast. In line with one supply, the Trump...
Pharmaceutical Updates
MHRA approves GSK’s oral antibiotic for UTIs in females
The remedy is for females 12 years and above with a minimal physique weight of 40kg. Credit score: MAXSHOT.PL/Shutterstock.com. The...
We’re studying about FDA Covid shot insurance policies, U.Ok. Mounjaro provide
Rise and shine, everybody, one other busy day is on the best way. Or is it? With a looming vacation...
Webinar: AI for Sooner, Extra Exact Actual-World Analysis: Extracting Scientific Notes Knowledge at Scale
Register to look at Actual-world knowledge provides highly effective alternatives to check illness development, therapy security and effectiveness, and affected...
FDA bans Ixchiq within the US, sending Valneva shares plummeting
Ixchiq contributed €7.5m to Valneva’s €91m whole product gross sales in H1 2025. Credit score: Ink Drop by way of...
We’re studying about AbbVie psychedelic deal, Lilly weight problems tablet trial
Prime of the morning to you, and a high quality one it's. Clear blue skies and nice breezes are wafting...
Biotech Lastly Has an IPO After Months-Lengthy Freeze
The biotech IPO freeze has lastly thawed. LB Pharma, a biotech growing therapies for neuropsychiatric problems, is planning an preliminary...
Navigating regulatory change in APAC: Insights from the upcoming BioSecure Act Webinar
The BioSecure Act is ready to reshape the regulatory panorama throughout APAC – and understanding its implications is important for...
FDA to publish day by day studies of hostile occasions tied to medication
WASHINGTON — The Meals and Drug Administration introduced Friday that it has begun publishing studies of hostile occasions regarding medication...
Which Weight Loss Therapies Will Be Most Efficient?
The weight problems market has changed into one of the crucial cut-throat market battles in pharma historical past, with dozens...
Bavarian Nordic boosts 2025 steerage as takeover supply looms
Bavarian Nordic posted complete income for H1 of DKr3bn ($160m), reflecting a 33% in comparison with the identical interval final...
STAT+: Up and down the ladder: The newest comings and goings
Employed somebody new and thrilling? Promoted a rising star? Lastly solved that hard-to-fill spot? Share the information with us, and...
Washington’s Life Sciences Scene Strikes Past Analysis Roots
As Washington’s life sciences scene has expanded past being a high analysis cluster, its workforce has elevated considerably, in line...
Pfizer battles one other Paxlovid lawsuit from Enanta
In case you don’t succeed at first, strive once more – in separate areas. That’s the motto Enanta Prescription drugs...
STAT+: Was the response to Viking’s oral information overblown?
Need to keep on prime of the science and politics driving biotech right now? Join to get our biotech e-newsletter in your...
